Literature DB >> 11058874

Characterization of a mutant E-cadherin protein encoded by a mutant gene frequently seen in diffuse-type human gastric carcinoma.

Y Fukudome1, K Yanagihara, M Takeichi, F Ito, S Shibamoto.   

Abstract

The cell-cell adhesion molecule E-cadherin plays an essential role in the maintenance and function of epithelial tissues. Altered expression of E-cadherin has been implicated in tumor invasion. Analysis of mutations of the human E-cadherin gene in gastric carcinoma of the diffuse type has revealed that deletion of exon 8 or 9 in its cDNA appears to be predominant. In this study, we carried out structural and functional analyses of a mutant form of E-cadherin in a cell line, HSC45-M2, established from a human signet ring-cell carcinoma. Although immunohistochemical analysis showed that the mutant cadherin was localized at cell-cell contact sites as usually seen with the wild type, these cells did not form compact colonies. HSC45-M2 cells expressed aberrant E-cadherin with an m.w. larger than that of the wild type. In these cells, we found deletion of the exon 9-intron 9 boundary including the splicing donor site in E-cadherin genomic DNA. RT-PCR indicated 2 transcripts, which appeared to be caused by the splicing defect. Northern blotting, however, showed that the transcript lacking exon 9 was predominantly detected in these cells. The electrophoretic mobilities on SDS-PAGE of the mutant E-cadherin protein in HSC45-M2 cells and the protein expressed from cDNA lacking exon 9 appeared identical. Analysis of the amino-terminal region of the mutant E-cadherin protein revealed that the cadherin was capable of becoming a mature form by removal of its amino-terminal peptide. However, the mutant E-cadherin was susceptible to trypsinization in the presence of Ca(2+), which is not the case for wild-type E-cadherin, suggesting that the mutant E-cadherin frequently found in diffuse-type gastric carcinoma may have lost its Ca(2+)-binding ability, leading to disruption of the tight cell-cell association. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11058874     DOI: 10.1002/1097-0215(20001115)88:4<579::aid-ijc10>3.0.co;2-u

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  11 in total

1.  177Lu-immunotherapy of experimental peritoneal carcinomatosis shows comparable effectiveness to 213Bi-immunotherapy, but causes toxicity not observed with 213Bi.

Authors:  Christof Seidl; Christine Zöckler; Roswitha Beck; Leticia Quintanilla-Martinez; Frank Bruchertseifer; Reingard Senekowitsch-Schmidtke
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-11-12       Impact factor: 9.236

2.  Differential gene expression triggered by highly cytotoxic alpha-emitter-immunoconjugates in gastric cancer cells.

Authors:  Christof Seidl; Matthias Port; Christos Apostolidis; Frank Bruchertseifer; Markus Schwaiger; Reingard Senekowitsch-Schmidtke; Michael Abend
Journal:  Invest New Drugs       Date:  2009-01-13       Impact factor: 3.850

3.  Cell death triggered by alpha-emitting 213Bi-immunoconjugates in HSC45-M2 gastric cancer cells is different from apoptotic cell death.

Authors:  Christof Seidl; Hedwig Schröck; Sabine Seidenschwang; Roswitha Beck; Ernst Schmid; Michael Abend; Karl-Friedrich Becker; Christos Apostolidis; Tuomo K Nikula; Elisabeth Kremmer; Markus Schwaiger; Reingard Senekowitsch-Schmidtke
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-10-02       Impact factor: 9.236

4.  Expression of E-cadherin and beta-catenin in gastric carcinoma and its correlation with the clinicopathological features and patient survival.

Authors:  Yong-Ning Zhou; Cai-Pu Xu; Biao Han; Min Li; Liang Qiao; Dian-Chun Fang; Jian-Min Yang
Journal:  World J Gastroenterol       Date:  2002-12       Impact factor: 5.742

5.  Alpha-catenin expression is decreased in patients with gastric carcinoma.

Authors:  Yong-Ning Zhou; Cai-Pu Xu; Yu Chen; Biao Han; Shi-Ming Yang; Dian-Chun Fang
Journal:  World J Gastroenterol       Date:  2005-06-14       Impact factor: 5.742

6.  Tumor specificity and in vivo targeting of an antibody against exon 9 deleted E-cadherin in gastric cancer.

Authors:  Hyuk-Joon Lee; Hye Seung Lee; Keun Hur; Woo Ho Kim; Kazuyoshi Yanagihara; Karl-Friedrich Becker; Kuhn Uk Lee; Han-Kwang Yang
Journal:  J Cancer Res Clin Oncol       Date:  2007-06-19       Impact factor: 4.553

7.  Effect of P-selectin monoclonal antibody on metastasis of gastric cancer and immune function.

Authors:  Jin-Lian Chen; Wei-Xiong Chen; Jin-Shui Zhu; Ni-Wei Chen; Tong Zhou; Ming Yao; Dong-Qing Zhang; Yun-Lin Wu
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

Review 8.  CDH1 germline mutation in hereditary gastric carcinoma.

Authors:  Hai-Dan Wang; Jun Ren; Lian Zhang
Journal:  World J Gastroenterol       Date:  2004-11-01       Impact factor: 5.742

9.  Non-invasive visualisation of the development of peritoneal carcinomatosis and tumour regression after 213Bi-radioimmunotherapy using bioluminescence imaging.

Authors:  H Matthias Buchhorn; Christof Seidl; Roswitha Beck; Dieter Saur; Christos Apostolidis; Alfred Morgenstern; Markus Schwaiger; Reingard Senekowitsch-Schmidtke
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-01-06       Impact factor: 10.057

10.  Silencing of claudin-11 is associated with increased invasiveness of gastric cancer cells.

Authors:  Rachana Agarwal; Yuriko Mori; Yulan Cheng; Zhe Jin; Alexandru V Olaru; James P Hamilton; Stefan David; Florin M Selaru; Jian Yang; John M Abraham; Elizabeth Montgomery; Patrice J Morin; Stephen J Meltzer
Journal:  PLoS One       Date:  2009-11-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.